A recent report identified MYC SVs in 42% of newly diagnosed MM, and in 24% of smoldering MM (sMM) cases, whereas these were absent in monoclonal gammopathy of undetermined significance (MGUS) cases. This evidence concerns the gene MYC and Miyoshi myopathy.